Erectile Dysfunction Premature Ejaculation Tadalafil Lidocaine Erectile Dysfunction Premature Ejaculation Randomized Controlled Trial Sexual Function Clinical Study
Conditions
Interventions
Participants take 20mg Tadalafil weekly for 12 weeks.,Participants take 20mg Tadalafil and use Lidocaine spray weekly for 12 weeks.
Active Comparator Drug,Experimental Drug
Tadalafil,Tadalafil and Lidocaine Spray
Sponsors
The First Affiliated Hospital of Gannan Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Couples who have had regular sexual activity within the past six months. Patients with a detailed medical history (including sexual history) and a comprehensive physical examination. Eligible patients underwent a four-week screening diagnostic period, recording the number of sexual activities, intra-vaginal ejaculation latency period, sexual performance, and satisfaction, etc. Exclusions were made for heart failure, chronic prostatitis/chronic pelvic pain syndrome, paraplegia, depression, etc.
Exclusion criteria
Exclusion criteria: Heart failure Chronic prostatitis/prostatodynia Paraplegia Depression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Index of Erectile Function-5 12 weeks International Index of Erectile Function Questionnaire,Sexual Satisfaction Score (SSS) 12 weeks Sexual Satisfaction Questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Intravaginal Ejaculatory Latency Time 12 weeks Intra-Vaginal Ejaculation Latency Time | — |
Countries
China
Contacts
Public ContactMin Liu
Gannan Medical University
Outcome results
None listed